For: | Lin CR, Lee YK, Chiang CJ, Yang YW, Chang HC, You SL. Secular trends of intrahepatic cholangiocarcinoma in a high endemic area: A population-based study. World J Gastroenterol 2022; 28(28): 3695-3705 [PMID: 36161044 DOI: 10.3748/wjg.v28.i28.3695] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i28/3695.htm |
Number | Citing Articles |
1 |
Feng Yi Cheo, Kai Siang Chan, Vishal G Shelat. Outcomes of liver resection in hepatitis C virus-related intrahepatic cholangiocarcinoma: A systematic review and meta-analysis. World Journal of Virology 2024; 13(1): 88946 doi: 10.5501/wjv.v13.i1.88946
Abstract(372) |
Core Tip(340) |
Full Article(HTML)(1396)
|
Full Article with Cover (PDF)-3560K(72)
|
Full Article (Word)-244K(3)
|
Audio-1677K(5)
|
Peer-Review Report-216K(39)
|
Answering Reviewers-63K(43)
|
Supplementary Material-110K(45)
|
Full Article (PDF)-962K(77)
|
Full Article (XML)-202K(41)
|
Times Cited (0)
|
Total Visits (3769)
|
Open
|
2 |
Xiaoping Zheng, Huiying Li, Jian Lin, Ping Li, Xuexi Yang, Zhumei Luo, Li Jin. METTL3-mediated m6A modification promotes chemoresistance of intrahepatic cholangiocarcinoma by up-regulating NRF2 to inhibit ferroptosis in cisplatin-resistant cells. Journal of Chemotherapy 2024; : 1 doi: 10.1080/1120009X.2024.2421700
|
3 |
Leva Gorji, Hussein Aoun, Jeffrey Critchfield, Najeeb Al Hallak, Eliza W. Beal. Locoregional Therapy for Intrahepatic Cholangiocarcinoma: The Role of Intra-Arterial Therapies. Cancers 2023; 15(19): 4727 doi: 10.3390/cancers15194727
|